Bogart Wealth LLC Cuts Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Bogart Wealth LLC trimmed its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 13,655 shares of the healthcare conglomerate’s stock after selling 30 shares during the quarter. Bogart Wealth LLC’s holdings in UnitedHealth Group were worth $7,189,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently made changes to their positions in the stock. Bray Capital Advisors boosted its stake in shares of UnitedHealth Group by 0.5% during the 3rd quarter. Bray Capital Advisors now owns 9,616 shares of the healthcare conglomerate’s stock valued at $4,848,000 after purchasing an additional 50 shares in the last quarter. Sage Mountain Advisors LLC raised its position in shares of UnitedHealth Group by 15.7% in the 3rd quarter. Sage Mountain Advisors LLC now owns 3,528 shares of the healthcare conglomerate’s stock worth $1,779,000 after acquiring an additional 479 shares in the last quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH boosted its position in shares of UnitedHealth Group by 2.9% during the third quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH now owns 105,860 shares of the healthcare conglomerate’s stock valued at $53,374,000 after purchasing an additional 3,023 shares in the last quarter. Vantage Investment Partners LLC lifted its position in UnitedHealth Group by 13.4% during the third quarter. Vantage Investment Partners LLC now owns 84,324 shares of the healthcare conglomerate’s stock valued at $42,515,000 after buying an additional 9,979 shares during the period. Finally, Telemus Capital LLC increased its stake in shares of UnitedHealth Group by 2.6% in the 3rd quarter. Telemus Capital LLC now owns 19,338 shares of the healthcare conglomerate’s stock worth $9,750,000 after acquiring an additional 491 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 0.7 %

Shares of NYSE UNH traded up $3.34 during midday trading on Thursday, reaching $506.55. 315,744 shares of the company’s stock traded hands, compared to its average volume of 4,317,021. The company has a quick ratio of 0.79, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. The company has a market cap of $466.07 billion, a price-to-earnings ratio of 30.81, a P/E/G ratio of 1.43 and a beta of 0.55. The stock’s 50 day simple moving average is $481.45 and its 200-day simple moving average is $511.98. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $554.70.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, beating the consensus estimate of $6.63 by $0.28. The business had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The company’s quarterly revenue was up 8.6% on a year-over-year basis. During the same period in the prior year, the firm posted $6.26 earnings per share. On average, analysts predict that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were paid a dividend of $1.88 per share. The ex-dividend date was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.48%. UnitedHealth Group’s payout ratio is 45.97%.

Analysts Set New Price Targets

UNH has been the subject of a number of analyst reports. HSBC raised shares of UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 target price for the company in a research note on Thursday, April 4th. Deutsche Bank Aktiengesellschaft upped their price target on shares of UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a research note on Friday, April 19th. TD Cowen lowered their price target on UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a report on Wednesday, April 10th. Cantor Fitzgerald restated an “overweight” rating and set a $591.00 price target on shares of UnitedHealth Group in a research note on Wednesday, April 10th. Finally, Truist Financial restated a “buy” rating and set a $600.00 target price on shares of UnitedHealth Group in a research report on Wednesday, April 17th. Four analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to MarketBeat, UnitedHealth Group has an average rating of “Moderate Buy” and an average price target of $570.05.

Insider Buying and Selling

In other news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at $4,527,306.72. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is owned by company insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.